About the Authors

Quynh T Phan, Carter L Myers, Yue Fu, Michael R Yeaman, Ashraf S Ibrahim, John E Edwards Jr., Scott G Filler
Department of Medicine, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California, United States of America

Yue Fu, Michael R Yeaman, Ashraf S Ibrahim, John E Edwards Jr., Scott G Filler
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Donald C Sheppard
Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada

William H Welch
Department of Biochemistry, University of Nevada Reno, Reno, Nevada, United States of America

Corresponding Author

sfiller@ucla.edu

Competing Interests

YF, MRY, ASI, JEE, and SGF have equity in NovaDigm Therapeutics, Inc.

Author Contributions

QTP, CLM, YF, DCS, MRY, WHW, ASI, JEE, and SGF conceived and designed the experiments. QTP, CLM, YF, WHW, and ASI performed the experiments. QTP, CLM, YF, DCS, MRY, WHW, and SGF analyzed the data. WHW and ASI contributed reagents/materials/analysis tools. DCS, MRY, JEE, and SGF wrote the paper.